Výsledky vyhledávání - "D. A. Katzenstein"

Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253

Autor: D. K. Katzenstein, Kevin P. Cain, J. M. Achkar, A. E. Omoz-Oarhe, Caroline H. Shiboski, Rob Roy MacGregor, Janet Andersen, Valdilea G. Veloso, Santhanalakshmi Gengiah, A. Asmelash, Lauren Komarow, Amita Gupta, Susan Swindells, Srikanth Tripathy, Sonia Qasba, Umesh G. Lalloo, Randy D. Allen

Publikováno v: The International Journal of Tuberculosis and Lung Disease. 17:532-539

Millions of human immunodeficiency virus (HIV) infected individuals will initiate antiretroviral treatment (ART) in settings where tuberculosis (TB) is endemic.1 The increasing prevalence of HIV infection has resulted in a 3- to 10-fold increase in a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74acbc3ebf26a4263ce4b7ae9447bd2
https://doi.org/10.5588/ijtld.12.0737

Zobrazit plný text záznamu

A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe

Autor: L S, Zijenah, G, Kadzirange, S, Rusakaniko, T, Kufa, N, Gonah, O, Tobaiwa, C, Gwanzura, E, Matsikire, D A, Katzenstein

Publikováno v: The Central African journal of medicine. 52(1-2)

A pilot study to assess effectiveness of generic Nevirapine (NVP)+Zidovudine (AZT)+Lamivudine (3TC) as potent antiretroviral therapy (ART) in women exposed to either SD NVP or short course (SC) AZT through participation in prevention of mother-to-chi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fcf1a9e5a95a951f76445caeef654473
https://pubmed.ncbi.nlm.nih.gov/17892232

Zobrazit plný text záznamu

Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals

Autor: J M, Raboud, J S, Montaner, S, Rae, J, Kahn, S M, Hammer, D A, Katzenstein, A, Pavia, R, Dolin, M D, Hughes, A, Cross, M, Beltangady, J, Gatell, L, Dunkle, L, Smaldone

Publikováno v: Antiviral therapy. 2(4)

A meta-analysis of the original data from 2411 patients in the ACTG 116A, ACTG116B/117, ACTG175, BMS010 and CTN002 trials was conducted to improve the estimate of the effect of switching from zidovudine to didanosine on rates of clinical progression,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7096a1db14deafa718b7c04d0a3d9573
https://pubmed.ncbi.nlm.nih.gov/11327443

Zobrazit plný text záznamu

Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team

Autor: J S, Currier, C, Spino, J, Grimes, C B, Wofsy, D A, Katzenstein, M D, Hughes, S M, Hammer, D J, Cotton

Publikováno v: Journal of acquired immune deficiency syndromes (1999). 24(4)

To prospectively examine differences in baseline characteristics and study outcomes between HIV-infected women and men during a clinical trial of nucleoside analogue therapy.ACTG 175 randomized HIV-infected patients with CD4+ counts between 200 and 5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::708b1f78ec3ace1989d6dc3f9fca841d
https://pubmed.ncbi.nlm.nih.gov/11015147

Zobrazit plný text záznamu

Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group

Autor: D A, Katzenstein, M, Hughes, M, Albrecht, S, Hammer, M, Para, R, Murphy, H, Valdez, R, Haubrich, S, Liou

Publikováno v: AIDS research and human retroviruses. 16(11)

Clinical benefit of zidovudine alone in the treatment of HIV infection wanes after several years, with decreasing CD4+ cell numbers and increasing HIV RNA in plasma. To develop treatment strategies following prolonged zidovudine treatment, 92 subject

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8d6e83a7556a883b9b409863e9a89c8d
https://pubmed.ncbi.nlm.nih.gov/10933617

Zobrazit plný text záznamu

Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response

Autor: N S, Shulman, A R, Zolopa, D J, Passaro, U, Murlidharan, D M, Israelski, C L, Brosgart, M D, Miller, S, Van Doren, R W, Shafer, D A, Katzenstein

Publikováno v: Journal of acquired immune deficiency syndromes (1999). 23(3)

To determine the impact of prior nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy, genotypic resistance, and other variables on response to efavirenz (EFV)- and adefovir dipivoxil (ADV)-based salvage therapy.Retrospective clinical cohort

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6f0bd8c29b0cd893750054437aa22b5a
https://pubmed.ncbi.nlm.nih.gov/10839657

Zobrazit plný text záznamu

Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

Autor: S, Kim, M D, Hughes, S M, Hammer, J B, Jackson, V, DeGruttola, D A, Katzenstein

Publikováno v: AIDS research and human retroviruses. 16(7)

To evaluate HIV-1 RNA and CD4+ cell responses to therapy as predictors of clinical progression and to evaluate levels and trends of these markers prior to clinical failure, HIV-1 RNA measurements were retrospectively obtained on subjects who progress

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a9259d64f0f8909d9bb90f464f1f71a3
https://pubmed.ncbi.nlm.nih.gov/10791875

Zobrazit plný text záznamu

The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program

Autor: D, Brambilla, P S, Reichelderfer, J W, Bremer, D E, Shapiro, R C, Hershow, D A, Katzenstein, S M, Hammer, B, Jackson, A C, Collier, R S, Sperling, M G, Fowler, R W, Coombs

Publikováno v: AIDS (London, England). 13(16)

To assess the specific contributions of assay variation and biological variation to the total variation of plasma HIV-1 RNA measured by the Roche Monitor assay and the extent to which batch assays reduced both assay variability and total variability

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::59c89826a395e2b7125013a4b714605e
https://pubmed.ncbi.nlm.nih.gov/10563712

Zobrazit plný text záznamu

Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team

Autor: D M, Simpson, D A, Katzenstein, M D, Hughes, S M, Hammer, D L, Williamson, Q, Jiang, J T, Pi

Publikováno v: AIDS (London, England). 12(18)

To determine the frequency of peripheral neuropathy and myopathy in HIV-infected subjects enrolled in a combination antiretroviral treatment trial.AIDS Clinical Trial Group (ACTG) protocol 175 was a multicenter, double-blind, placebo-controlled, clin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::93579b08e33d87813b6b43342a54f661
https://pubmed.ncbi.nlm.nih.gov/9875580

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání